FDA recall record

Mastisol Liquid Adhesive Liquid Adhesive recall — FDA Z-1005-2026

Butyrate tube cracks during actuation, rendering product unusable.

Class IIclassification
Z-1005-2026official record ID
Jan 7, 2026report date

Recall record at a glance

Official recordZ-1005-2026
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmFerndale Laboratories, Inc.
Report dateJan 7, 2026
Recall initiation dateNov 25, 2025
Quantity24589
LocationFerndale, MI, United States

Official product description

Brand Name: Mastisol Liquid Adhesive Product Name: Liquid Adhesive Model/Catalog Number: 0523-48 Product Description: Liquid adhesive, 2/3 mL vial, 48 vials per carton Component: No

Why the product was recalled

Butyrate tube cracks during actuation, rendering product unusable.

Distribution information

Worldwide distribution - US Nationwide and the country of UK.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.